mRNA |
GSK269962A |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.004 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.005 |
mRNA |
masitinib |
GDSC1000 |
pan-cancer |
AAC |
-0.096 |
0.005 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.005 |
mRNA |
VNLG/124 |
GDSC1000 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
-0.095 |
0.006 |
mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.006 |
mRNA |
Bleomycin |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
S-Trityl-L-cysteine |
GDSC1000 |
pan-cancer |
AAC |
-0.14 |
0.006 |
mRNA |
BX-795 |
GDSC1000 |
pan-cancer |
AAC |
-0.097 |
0.007 |